glp 1 agonist vs sglt2 inhibitor Recommendations for SGLT2i versus GLP-1 RA on the basis of kidney View of Diabetes medications with
Description
Read more Latest News Worth Exploring Why JCS Analytics JCS Analytics explores how data, technology, and sound analytical judgment can turn complex information into clearer, more useful insight
Some GLP-1 and related medications are approved for chronic weight management in eligible adults without diabetes
A total of 112 articles were initially identified through comprehensive database searches
25 Given concerns that skeletal muscle loss may predispose patients to long-term metabolic complications, including sarcopenia, it is recommended that individuals undergoing treatment with GLP-1 RAs receive adequate protein intake and appropriate micronutrient supplementation to preserve muscle mass and function, thereby maximizing the clinical benefits of therapy
Researchers are also evaluating retatrutide for type 2 diabetes (TRIUMPH-2), cardiovascular outcomes (TRIUMPH-3), and other conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD)
ASAT, abdominal subcutaneous adipose tissue
